The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis
Abstract
Objective: Osteoarthritis (OA) is one of the most prevalent and disabling chronic conditions affecting the elderly. Its etiology is largely unknown, but age is the most prominent risk factor. The current study was designed to test whether accumulation of advanced glycation end products (AGEs), which are known to adversely affect cartilage turnover and mechanical properties, provides a molecular mechanism by which aging contributes to the development of OA. Methods: The hypothesis that elevated AGE levels predispose to the development of OA was tested in the canine anterior cruciate ligament transection (ACLT) model of experimental OA. Cartilage AGE levels were enhanced in young dogs by intraarticular injections of ribose. This mimics the accumulation of AGEs without the interference of other age‐related changes. The severity of OA was then assessed 7 weeks after ACLT surgery in dogs with normal versus enhanced AGE levels. Results: Intraarticular injections of ribose enhanced cartilage AGE levels ∼5‐fold, which is similar to the normal increase that is observed in old dogs. ACLT surgery resulted in more‐pronounced OA in dogs with enhanced AGE levels. This was observed as increased collagen damage and enhanced release of proteoglycans. The attempt to repair the matrix damage was impaired; proteoglycan synthesis and retention were decreased at enhanced AGE levels. Mankin grading of histology sections also revealed more‐severe OA in animals with enhanced AGE levels. Conclusion: These findings demonstrate increased severity of OA at higher cartilage AGE levels and provide the first in vivo experimental evidence for a molecular mechanism by which aging may predispose to the development of OA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., & Stern, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118175 · Cited by 896
Cited by
Osteoarthritis: an update with relevance for clinical practice
Bijlsma, J. W., Berenbaum, F., & Lafeber, F. P. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60243-2 · Cited by 2,288
Self-citationWhat is Intervertebral Disc Degeneration, and What Causes It?
Adams, M. A., & Roughley, P. J. (2006) · Spine · doi:10.1097/01.brs.0000231761.73859.2c · Cited by 1,780
Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis
Hwang, H., & Kim, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125943 · Cited by 886
Loeser, R. F. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.03.002 · Cited by 726
Why is osteoarthritis an age-related disease?
Shane Anderson, A., & Loeser, R. F. (2010) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.08.006 · Cited by 669
Metadata
- Authors
- DeGroot, J., Verzijl, N., Wenting‐Van Wijk, M. J. G., Jacobs, K. M. G., Van El, B., Van Roermund, P. M., Bank, R. A., Bijlsma, J. W. J., TeKoppele, J. M., & Lafeber, F. P. J. G.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 50
- Issue
- 4
- Pages
- 1207-1215
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2009827516
- Cited by
- 215
- References
- 2
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. https://app.cochat.ai/papers/10.1002/art.20170
- The paper
- DeGroot, J., Verzijl, N., Wenting‐Van Wijk, M. J. G., Jacobs, K. M. G., Van El, B., Van Roermund, P. M., Bank, R. A., Bijlsma, J. W. J., TeKoppele, J. M., & Lafeber, F. P. J. G. (2004). Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.20170
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.